LCN2 and chronic kidney disease: In this study, to further test if NGAL might be an ideal biomarker to monitor AKI-to-CKD progression, we found a positive correlation between the concentration of NGAL in body fluid and the extent of tubulointerstitial fibrosis in kidney sections of IRI mice.